MICHAEL VASCONCELLES

CIK 1734755 · Head of Research and Dev. · last filed 2026-06-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

13

Lifetime Open-Market Net

-$31.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KURA Director $9.05 $0 3 2026-06-04
Day One Biopharmaceuticals, Inc. (DAWN) Delisted Head of Research and Dev. 0 $21.53 $0 -$31.6K 4 2026-04-23
ImmunoGen, Inc. (IMGN) Delisted EVP R&D & MEDICAL AFFAIRS 0 $31.23 $0 $0 4 2024-02-12
Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Director $11.19 $0 1 2022-08-17
Cogent Biosciences, Inc. (UMRX) Delisted Chief Medical Officer $0 1 2019-04-11

Recent Filings · Page 2 of 2

13 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-01-03 ImmunoGen, Inc. (IMGN) Delisted Grant (A) $0 EDGAR
2022-08-17 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Grant (A) $0 EDGAR
2019-04-11 Cogent Biosciences, Inc. (UMRX) Delisted Grant (A) $0 EDGAR
Showing 1113 of 13
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.